Get the Stockscreener App
10.67
1.15%
0.1896
Ardent Health Inc stock is traded at $10.67, with a volume of 28,637.
It is up +1.15% in the last 24 hours and up +1.44% over the past month.
Ardent Health Inc is a provider of healthcare in growing mid-sized urban communities across the U.S and operating in eight growing mid-sized urban markets across six states Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. The main focus on people and investments in services and technologies.
See More
Previous Close:
$10.48
Open:
$10.51
24h Volume:
28,637
Relative Volume:
0.05
Market Cap:
$1.50B
Revenue:
$6.32B
Net Income/Loss:
$230.14M
P/E Ratio:
11.12
EPS:
0.9598
Net Cash Flow:
$256.03M
1W Performance:
-2.84%
1M Performance:
+1.44%
6M Performance:
+12.65%
1Y Performance:
-16.93%
1-Day Range:
$10.35
$10.82
1-Week Range:
$10.35
$11.28
52-Week Range:
$7.71
$15.48
Ardent Health Inc Stock (ARDT) Company Profile
Name
Ardent Health Inc
Sector
Industry
Phone
(615) 296-3000
Address
340 SEVEN SPRINGS WAY, BRENTWOOD
Compare ARDT vs HCA, THC, FMS, EHC, DVA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARDT
Ardent Health Inc
|
10.60 | 1.50B | 6.32B | 230.14M | 256.03M | 0.9598 |
HCA
Hca Healthcare Inc
|
423.55 | 88.13B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
278.23 | 21.62B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
23.50 | 12.69B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
122.17 | 12.01B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
174.35 | 11.31B | 13.84B | 1.10B | 1.49B | 10.42 |
Ardent Health Inc Stock (ARDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-17-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-14-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-14-25 | Initiated | Goldman | Neutral |
| Sep-10-25 | Initiated | UBS | Buy |
| Jul-16-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| Nov-06-24 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-12-24 | Initiated | BofA Securities | Buy |
| Aug-12-24 | Initiated | Citigroup | Buy |
| Aug-12-24 | Initiated | JP Morgan | Neutral |
| Aug-12-24 | Initiated | Leerink Partners | Outperform |
| Aug-12-24 | Initiated | Loop Capital | Buy |
| Aug-12-24 | Initiated | Mizuho | Outperform |
| Aug-12-24 | Initiated | Morgan Stanley | Overweight |
| Aug-12-24 | Initiated | RBC Capital Mkts | Outperform |
| Aug-12-24 | Initiated | Stephens | Overweight |
| Aug-12-24 | Initiated | Truist | Buy |
View All
Ardent Health Inc Stock (ARDT) Latest News
Ardent Health (NYSE: ARDT) ex-exec lines up six-figure stock sale - Stock Titan
Ardent Health’s BSA Health System partners with Cardiology Center of Amarillo to expand heart care access - Bitget
Ardent Health (NYSE: ARDT) ex-exec lines up 2026 sale of stock grants - Stock Titan
Sei Investments Co. Lowers Stock Holdings in Ardent Health, Inc. $ARDT - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
2026-08-16 | Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Stockholders to Inquire about Securities Investigation | NYSE:ARDT | Press Release - Stockhouse
ARDT Q2 2026 Earnings: EPS Misses Estimates by 35.06% as Stock DeclinesFinal Results - Vinanet
Why Ardent Health (ARDT) Is Down 5.5% After Cutting 2026 Guidance And Fueling Options JittersAnd What's Next - simplywall.st
Wedge Capital Management L L P NC Acquires 222,447 Shares of Ardent Health, Inc. $ARDT - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Implied Volatility Surging for Ardent Health Stock Options - Yahoo Finance
Ardent Health, Inc. (ARDT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Ardent Health (ARDT) Q2 2026 Earnings Call Transcript - The Globe and Mail
ARDT WRITE OFFS: Hagens Berman Investigating Claims Against Ardent Health (ARDT) Over Alleged $97M Accounting Shock and "180-Day Cliff" Reserves (PR Newswire) - Aktiellt
A next-generation heart pump is tested during high-risk stenting - Stock Titan
Ardent Health, Inc. (ARDT) Stock Analysis: Exploring a 13.84% Potential Upside for Investors - DirectorsTalk Interviews
RBC Capital raises Ardent Health stock price target on EBITDA beat By Investing.com - Investing.com Australia
RBC Capital raises Ardent Health stock price target on EBITDA beat - Investing.com India
Ardent Moves on From Managers, Bumps Cost-Cutting Plan to $70M+ - HCI Innovation Group
RBC Adjusts PT on Ardent Health Partners to $13 From $12, Maintains Outperform Rating - marketscreener.com
Goldman Sachs Maintains Ardent Health(ARDT.US) With Hold Rating, Maintains Target Price $13 - Moomoo
Bronstein, Gewirtz & Grossman, LLC Is Investigating Ardent Health, Inc. (ARDT) And Encourages Investors to Connect - ACCESS Newswire
ARDT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Ardent Health (NYSE:ARDT) Rating Lowered to Strong Sell at Zacks Research - MarketBeat
Is Ardent Health (ARDT) Cheap On Lowered Guidance And Weaker Q2 Earnings? - Yahoo Finance
A Quick Look at Today's Ratings for Ardent Health(ARDT.US), With a Forecast Between $12 to $13 - Moomoo
New Strong Sell Stocks for August 7th - The Globe and Mail
Ardent Health, Inc. (NYSE:ARDT) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Guggenheim raises Ardent Health stock price target on EBITDA beat By Investing.com - Investing.com India
Ardent Health (NYSE:ARDT) Stock Price Expected to Rise, Truist Financial Analyst Says - MarketBeat
Guggenheim raises Ardent Health stock price target on EBITDA beat - Investing.com
A Quick Look at Today's Ratings for Ardent Health(ARDT.US), With a Forecast Between $9 to $14 - Moomoo
Truist Adjusts Price Target on Ardent Health Partners to $13 From $12, Maintains Buy Rating - Moomoo
Ardent Health Inc (ARDT) (Q2 2026) Earnings Call Highlights: Raising Impact Program Savings ... - Yahoo Finance UK
Ardent Health Q2 Earnings Call Highlights - TradingView
Earnings call transcript: Ardent Health Q2 2026 EPS misses as stock rises 8% - Investing.com Canada
Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Investors to Inquire about Securities Investigation - ACCESS Newswire
ARDT: Q2 results beat expectations with strong cost controls and reaffirmed 2026 guidance - TradingView
Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc - The National Law Review
Ardent Health Partners, LLC Q2 2026 Earnings Call Summary - Yahoo Finance
Why Ardent Health (ARDT) Is Down 6.3% After Cutting 2026 Earnings Guidance On Weaker Q2 Results - simplywall.st
First Trust Advisors LP Buys 198,595 Shares of Ardent Health, Inc. $ARDT - MarketBeat
Ardent Health Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Ardent Health, Inc. (ARDT) Q2 Earnings Lag Estimates - Yahoo Finance
ARDT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Ardent Health, Inc. (ARDT) Releases Q2 2026 Earnings: EPS Miss and Profitability Declines - Quiver Quantitative
Earnings Flash (ARDT) Ardent Health, Inc. Reports Q2 Revenue $1.62B, vs. FactSet Est of $1.59B - marketscreener.com
Ardent Health reports Q2 2026: $1.62B revenue, $17M net income, $115M adjusted EBITDA - TradingView
Tranche Update on Ardent Health, Inc.'s Equity Buyback Plan announced on November 18, 2025. - marketscreener.com
Ardent Health Reports Second Quarter 2026 Results - Business Wire
Ardent Health Inc (ARDT) Q2 2026 Earnings Report Preview: What To Look For - Yahoo Finance
Ardent Health Inc Stock (ARDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.20%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):